Patients registered in a sample of general practices
Measure:
Prescribing of specific types of drugs
Units:
Rates and number of cases
Dimensions:
Sex by Year by Drug Type by
Age
Dataset
0-34
35-44
45-54
55-64
65-74
75-84
85+
Crude rate (all ages)
Age-standardised rate (all ages)1
Males 1994
No. of patients with atrial fibrillation
129
119
378
719
1522
1450
399
4716
4716
Prevalence rate/1000
0.5
1.6
5.6
14.4
37.6
74.1
87.2
9.5
8.5
% prescribed oral anticoagulants
7.0
5.9
22.2
31.3
24.8
15.3
5.0
20.0
11.5
% prescribed aspirin
4.7
6.7
10.3
19.2
30.4
32.4
30.1
26.4
9.0
% prescribed cardiac glycosides
10.1
11.8
37.3
48.4
59.1
65.9
65.7
55.8
24.3
1995
No. of patients with atrial fibrillation
142
131
384
839
1657
1616
446
5215
5215
Prevalence rate/1000
0.6
1.7
5.3
15.9
39.5
76.2
91.4
10.0
8.9
% prescribed oral anticoagulants
6.3
7.6
21.6
34.7
29.8
19.8
8.3
23.9
12.3
% prescribed aspirin
2.1
6.1
10.2
21.9
35.6
36.7
35.7
30.2
8.8
% prescribed cardiac glycosides
6.3
13.7
32.3
44.9
57.6
62.9
63.2
53.3
20.3
1996
No. of patients with atrial fibrillation
149
152
430
919
1833
1859
509
5851
5851
Prevalence rate/1000
0.6
1.9
5.6
16.5
41.9
81.3
98.0
10.8
9.4
% prescribed oral anticoagulants
8.7
13.2
22.1
35.8
35.4
23.5
9.4
27.2
14.2
% prescribed aspirin
2.0
6.6
13.0
24.7
38.0
40.7
43.8
33.7
9.9
% prescribed cardiac glycosides
4.7
15.8
28.6
43.0
55.0
60.5
65.4
51.5
20.9
1997
No. of patients with atrial fibrillation
148
183
493
981
2008
2088
563
6464
6464
Prevalence rate/1000
0.6
2.2
6.1
16.7
44.3
86.4
101.8
11.4
9.9
% prescribed oral anticoagulants
7.4
11.5
26.6
38.5
39.4
28.2
11.9
30.7
14.6
% prescribed aspirin
2.0
7.1
11.2
25.4
37.8
41.6
47.2
34.3
9.9
% prescribed cardiac glycosides
4.7
13.7
27.0
38.9
51.9
58.2
62.0
48.8
19.1
1998
No. of patients with atrial fibrillation
145
227
557
1137
2179
2332
641
7218
7218
Prevalence rate/1000
0.5
2.5
6.6
18.0
46.2
90.5
106.2
12.1
10.4
% prescribed oral anticoagulants
5.5
12.3
28.0
42.0
41.4
33.3
13.6
33.7
15.4
% prescribed aspirin
2.1
8.8
12.7
26.4
38.2
44.3
48.5
35.6
11.1
% prescribed cardiac glycosides
4.1
10.6
24.8
37.0
47.8
56.3
58.8
46.0
16.5
Females 1994
No. of patients with atrial fibrillation
143
127
233
517
1351
2020
1176
5567
5567
Prevalence rate/1000
0.6
1.8
3.6
10.4
28.4
63.9
93.7
10.9
6.9
% prescribed oral anticoagulants
0.7
11.0
16.7
32.1
26.8
14.7
4.5
16.7
10.1
% prescribed aspirin
0.7
0.8
5.2
15.7
22.9
30.0
25.9
23.6
6.4
% prescribed cardiac glycosides
7.7
11.0
20.2
46.8
62.7
69.2
73.6
61.5
25.0
1995
No. of patients with atrial fibrillation
156
151
262
570
1415
2208
1284
6046
6046
Prevalence rate/1000
0.7
2.0
3.7
10.9
28.9
64.5
96.1
11.3
7.1
% prescribed oral anticoagulants
1.3
7.3
15.6
33.2
28.8
18.1
6.4
18.7
9.8
% prescribed aspirin
1.3
1.3
5.3
18.1
27.0
32.0
31.9
26.8
6.2
% prescribed cardiac glycosides
4.5
9.3
18.7
40.7
60.8
67.7
71.3
59.1
18.1
1996
No. of patients with atrial fibrillation
170
159
304
594
1482
2453
1348
6510
6510
Prevalence rate/1000
0.7
2.0
4.1
10.8
29.5
67.4
95.8
11.7
7.3
% prescribed oral anticoagulants
1.8
6.3
15.8
33.7
33.7
20.0
7.6
20.8
10.7
% prescribed aspirin
2.4
1.3
7.9
16.2
31.1
36.0
38.2
30.5
7.3
% prescribed cardiac glycosides
4.7
7.5
18.4
38.6
56.8
65.3
70.6
56.8
20.8
1997
No. of patients with atrial fibrillation
183
171
330
599
1633
2639
1479
7034
7034
Prevalence rate/1000
0.7
2.1
4.2
10.4
31.6
69.4
99.5
12.2
7.5
% prescribed oral anticoagulants
2.2
6.4
15.8
33.6
37.0
23.9
9.0
23.3
10.8
% prescribed aspirin
3.3
1.8
7.0
19.7
29.9
38.5
41.3
32.2
8.0
% prescribed cardiac glycosides
3.8
5.3
16.4
36.9
52.4
63.1
67.3
54.1
16.0
1998
No. of patients with atrial fibrillation
182
192
366
679
1759
2837
1733
7748
7748
Prevalence rate/1000
0.7
2.2
4.4
10.9
33.0
71.5
109.1
12.7
7.9
% prescribed oral anticoagulants
2.2
4.2
14.8
33.7
39.2
27.4
11.0
25.2
10.7
% prescribed aspirin
2.7
2.6
6.3
21.4
33.8
41.6
47.1
35.7
8.5
% prescribed cardiac glycosides
3.3
3.1
13.9
33.3
49.5
60.5
66.7
52.0
13.3
Footnotes
1 -
The age-standardised prescribing rates have been calculated using the European standard population. These age-standardised rates behave differently from the crude rates because the age structure of those with atrial fibrillation is very different from that of the European standard population. As a consequence, we would advise researchers interested in the prescribing rates to use the crude rates only.
Dataset Name:
5D3
Type of Dataset:
Cross-sectional
Description:
Taken from Key Health Statistics from General Practice 1998. Table 5D3: Prescribing of specific types of drugs for patients with atrial fibrillation by age, sex and calendar year: 1994-98
See Product details